Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blepharitis, Blood test, Influenza, Streptococcal infection
Clinical narrative: blepharitis, an eyelid infection, an autoimmune condition which is triggered by overactive immune system/The infection, clogged his eyelid both top and bottom along with lash line causing bacterial overgrowth, and itchiness; he was diagnosed with strep and flu 2 weeks ago; he was diagnosed with strep; This spontaneous case was reported by a consumer and describes the occurrence of BLEPHARITIS (blepharitis, an eyelid infection, an autoimmune condition which is triggered by overactive immune system/The infection, clogged his eyelid both top and bottom along with lash line causing bacterial overgrowth, and itchiness), INFLUENZA (he was diagnosed with strep and flu 2 weeks ago) and STREPTOCOCCAL INFECTION (he was diagnosed with strep) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (blood works done to check the level of antibody they have after getting 2 doses of the Moderna Covid-19 vaccines). Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLEPHARITIS (blepharitis, an eyelid infection, an autoimmune condition which is triggered by overactive immune system/The infection, clogged his eyelid both top and bottom along with lash line causing bacterial overgrowth, and itchiness), INFLUENZA (he was diagnosed with strep and flu 2 weeks ago) and STREPTOCOCCAL INFECTION (he was diagnosed with strep). At the time of the report, BLEPHARITIS (blepharitis, an eyelid infection, an autoimmune condition which is triggered by overactive immune system/The infection, clogged his eyelid both top and bottom along with lash line causing bacterial overgrowth, and itchiness) and INFLUENZA (he was diagnosed with strep and flu 2 weeks ago) was resolving and STREPTOCOCCAL INFECTION (he was diagnosed with strep) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: blood works done to check the level of antibody / His titer 10.5 months after booster dose was 66. His doctor only told him that he has high levels of the antibodies.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Patient reporting that a few weeks after getting booster dose, which was administered in mid Nov 2021, patient was diagnosed with Blepharitis, and it was relieved after taking eye drops and steroid eye cream. He had 4 episodes since.  Patient was seeking immunogenicity information about immune response to vaccine and how it was determined that a booster dose was needed as know immune response reduces over time. He also had relief since he was diagnosed with strep and flu 2 weeks ago.  Treatment drug was not reported.